Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PhRMA
Biotech
FDA proposes higher fees for ph. 1 trials conducted outside of US
The proposal is designed to incentivize U.S. drug development by tacking on higher fees for those not running phase 1 trials in the country.
Gabrielle Masson
Dec 3, 2025 5:19pm
Fierce Pharma
New US-EU trade deal includes 15% tariffs on pharmaceuticals
Jul 29, 2025 10:34am
Trial diversity nonprofit launches with FDA, Big Pharma vets
May 21, 2025 1:38pm
Amgen, Merck join academic clinical trial diversity partnership
Sep 16, 2024 3:10pm
AbbVie names CEO successor—Chutes & Ladders
Feb 23, 2024 9:30am
Biotech pipeline hosts 163 potential meds for mental illness
Jan 30, 2023 5:30am
